Artiva Biotherapeutics, Inc To Start Trading Tomorrow
Portfolio Pulse from Benzinga Insights
Artiva Biotherapeutics, Inc (NASDAQ:ARTV) is set to start trading on the NASDAQ exchange on July 19. The IPO price is expected to be between $14.00 and $16.00 per share, with an insider lock-up period of 180 days ending on January 15, 2025. Artiva is a clinical-stage biotechnology company focused on NK cell-based therapies for autoimmune diseases and cancers.
July 18, 2024 | 3:00 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Artiva Biotherapeutics, Inc (NASDAQ:ARTV) will begin trading on the NASDAQ exchange on July 19. The IPO price range is set between $14.00 and $16.00 per share. The insider lock-up period will last 180 days, ending on January 15, 2025.
The IPO of Artiva Biotherapeutics is a significant event as it marks the company's entry into the public market. The price range and lock-up period are crucial details for investors. The stock is likely to see initial interest and volatility as it begins trading.
CONFIDENCE 100
IMPORTANCE 90
RELEVANCE 100